fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds Calculator

Mutual Fund Calculator

Updated on October 17, 2020 , 2525 views

What is Mutual Fund?

A mutual fund is a professionally managed investment scheme. It is run by an asset management company (AMC) which acts like a mediator for the retail investors. The AMC pools in money from a large number of investors and invests it in equity shares, Bonds, money market instruments and other types of securities. Buying a mutual fund is like buying a small slice of a big pizza. Each investor, in return, is assigned a specific number of units proportionate to his invested amount in the fund. The investor is known as the unit holder. The unit holder shares the gains, losses, income and expenses of the fund in proportion to his investment in the fund.

What is a Mutual Fund Calculator ?

Mutual Fund Calculator helps us in Calculating our interest return for SIP investments or lump sum investment with the help of Fincash Mutual Fund Calculator below.

How does a mutual fund calculator work?

Is your mutual fund scheme generating returns in line with your expectation? Are you wondering what amount of SIP would help you in personal goal accomplishment? Get your answers by using our Mutual Fund Calculator! The Mutual Fund Calculator will give you the investment value at maturity by calculating fund returns according to your investment horizon. You can adjust the variables of the calculator like SIP/lump sum, amount of investment, frequency of SIP, expected rate of return and duration of SIP

Nature of investment ( SIP / Lumpsum )

There are basically two ways of Investing money in your favourite Mutual Funds. You can go via the SIP or the lump sum route

1. Lump sum investment

Under a lump sum, you invest one big chunk of your funds in mutual fund scheme of your choice. It generally happens when you receive huge corpus from say sale of an asset or retirement benefits. But investing a lump sum involves greater risk. That’s why it is always recommended to go via the SIP route

2. Systematic Investment Plan (SIP)

Under a SIP, you instruct the bank to deduct a? the fixed sum from your Savings Account every month and invest it in the said mutual fund scheme. In this way, you can buy units continuously without worrying about the right time to enter the market. You get the benefit of rupee cost averaging and enjoy the Power of Compounding

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Types of Calculators

Lumpsum Calculator

Know Your Lumpsum Amount

   
My Goal Amount:
Goal Tenure:
Years
Expected Annual Returns:
%

₹566,709 one time (Lumpsum)  for 10 Years
to achieve ₹2,500,000
Invest Now

SIP Calculator

Know Your SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹1,200,000
expected amount after 10 Years is ₹2,775,293.
Net Profit of ₹1,575,293
Invest Now

Top Funds for 2020

*Best funds based on 1 year performance.

1. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 14.2% since its launch.  Ranked 40 in Sectoral category.  Return for 2019 was 1.2% , 2018 was -7.5% and 2017 was 6.2% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund
Growth
Launch Date 28 Jun 99
NAV (19 Oct 20) ₹129.181 ↓ -1.19   (-0.91 %)
Net Assets (Cr) ₹586 on 30 Sep 20
Category Equity - Sectoral
AMC UTI Asset Management Company Ltd
Rating
Risk High
Expense Ratio 2.77
Sharpe Ratio 1.79
Information Ratio 0.39
Alpha Ratio 7.99
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Sep 15₹10,000
30 Sep 16₹9,340
30 Sep 17₹8,224
30 Sep 18₹8,901
30 Sep 19₹7,799
30 Sep 20₹12,984

UTI Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹340,450.
Net Profit of ₹40,450
Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Oct 20

DurationReturns
1 Month -2.6%
3 Month 17.2%
6 Month 32.3%
1 Year 63.9%
3 Year 15%
5 Year 4.6%
10 Year
15 Year
Since launch 14.2%
Historical performance (Yearly) on absolute basis
YearReturns
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
2014 43.7%
2013 23.3%
2012 24.8%
2011 -9.6%
2010 37.4%
Fund Manager information for UTI Healthcare Fund
NameSinceTenure
V Srivatsa3 Mar 173.58 Yr.

Data below for UTI Healthcare Fund as on 30 Sep 20

Equity Sector Allocation
SectorValue
Health Care92.82%
Basic Materials2.76%
Asset Allocation
Asset ClassValue
Cash4.42%
Equity95.58%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
11%₹64 Cr124,140
↓ -8,667
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
11%₹62 Cr1,239,120
↓ -50,672
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
8%₹45 Cr148,420
↓ -29,385
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
7%₹43 Cr559,275
↑ 47,090
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Jan 14 | 524494
6%₹36 Cr164,427
↓ -24,102
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
6%₹34 Cr848,211
↑ 241,414
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
4%₹25 Cr309,240
↓ -21,904
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596
4%₹24 Cr446,812
↓ -19,156
Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523
4%₹24 Cr533,700
↓ -12,684
Laurus Labs Ltd (Healthcare)
Equity, Since 30 Apr 20 | 540222
4%₹23 Cr786,180
↓ -365,340

2. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a CAGR/Annualized return of 14.1% since its launch.  Ranked 34 in Sectoral category.  Return for 2019 was -0.5% , 2018 was -9.9% and 2017 was 2.1% .

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund
Growth
Launch Date 31 Dec 04
NAV (19 Oct 20) ₹178.376 ↓ -1.50   (-0.83 %)
Net Assets (Cr) ₹1,434 on 30 Sep 20
Category Equity - Sectoral
AMC SBI Funds Management Private Limited
Rating
Risk High
Expense Ratio 2.44
Sharpe Ratio 1.81
Information Ratio -0.14
Alpha Ratio 8.46
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Sep 15₹10,000
30 Sep 16₹9,571
30 Sep 17₹8,069
30 Sep 18₹8,329
30 Sep 19₹7,208
30 Sep 20₹11,813

SBI Healthcare Opportunities Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹323,701.
Net Profit of ₹23,701
Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Oct 20

DurationReturns
1 Month -1.8%
3 Month 16.8%
6 Month 32.3%
1 Year 61.5%
3 Year 12.1%
5 Year 2.8%
10 Year
15 Year
Since launch 14.1%
Historical performance (Yearly) on absolute basis
YearReturns
2019 -0.5%
2018 -9.9%
2017 2.1%
2016 -14%
2015 27.1%
2014 56.8%
2013 26%
2012 37.1%
2011 -5.5%
2010 29.1%
Fund Manager information for SBI Healthcare Opportunities Fund
NameSinceTenure
Tanmaya Desai1 Jun 119.34 Yr.

Data below for SBI Healthcare Opportunities Fund as on 30 Sep 20

Equity Sector Allocation
SectorValue
Health Care97.22%
Basic Materials0.38%
Asset Allocation
Asset ClassValue
Cash2.4%
Equity97.6%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 20 | 500124
11%₹156 Cr300,000
↑ 20,000
Lupin Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500257
10%₹141 Cr1,400,000
Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087
10%₹139 Cr1,800,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
8%₹119 Cr1,500,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
8%₹110 Cr360,000
↑ 8,140
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA
7%₹100 Cr2,000,000
↓ -500,000
Strides Pharma Science Ltd (Healthcare)
Equity, Since 31 Mar 14 | STAR
5%₹65 Cr900,000
↓ -100,000
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Dec 19 | NH
4%₹57 Cr1,600,000
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 20 | APOLLOHOSP
3%₹47 Cr220,000
Sequent Scientific Ltd (Healthcare)
Equity, Since 31 Jul 14 | 512529
3%₹46 Cr3,000,000

3. Nippon India Pharma Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a CAGR/Annualized return of 21% since its launch.  Ranked 35 in Sectoral category.  Return for 2019 was 1.7% , 2018 was 3.6% and 2017 was 7.6% .

Below is the key information for Nippon India Pharma Fund

Nippon India Pharma Fund
Growth
Launch Date 5 Jun 04
NAV (19 Oct 20) ₹227.169 ↓ -2.62   (-1.14 %)
Net Assets (Cr) ₹3,911 on 30 Sep 20
Category Equity - Sectoral
AMC Nippon Life Asset Management Ltd.
Rating
Risk High
Expense Ratio 2.33
Sharpe Ratio 1.67
Information Ratio 1.02
Alpha Ratio 4.83
Min Investment 5,000
Min SIP Investment 100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Sep 15₹10,000
30 Sep 16₹9,404
30 Sep 17₹8,381
30 Sep 18₹10,297
30 Sep 19₹9,129
30 Sep 20₹14,672

Nippon India Pharma Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹367,070.
Net Profit of ₹67,070
Invest Now

Returns for Nippon India Pharma Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Oct 20

DurationReturns
1 Month -2.8%
3 Month 14.8%
6 Month 28.8%
1 Year 59.4%
3 Year 19.5%
5 Year 7.8%
10 Year
15 Year
Since launch 21%
Historical performance (Yearly) on absolute basis
YearReturns
2019 1.7%
2018 3.6%
2017 7.6%
2016 -10.6%
2015 19.4%
2014 49.5%
2013 20.9%
2012 34.8%
2011 -11%
2010 31.9%
Fund Manager information for Nippon India Pharma Fund
NameSinceTenure
Sailesh Raj Bhan1 Apr 0515.51 Yr.
Kinjal Desai25 May 182.35 Yr.

Data below for Nippon India Pharma Fund as on 30 Sep 20

Equity Sector Allocation
SectorValue
Health Care96.75%
Asset Allocation
Asset ClassValue
Cash3.25%
Equity96.75%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
How helpful was this page ?
POST A COMMENT